1 review

Juvelook 50mg

PDLLA + non-crosslinked HA hybrid collagen booster · 5 × 2 mL vials per box · VAIM Global, South Korea.

42.4 mgPDLLA per vial
7.5 mgNon-crosslinked HA
10–40 μmParticle size
6–12 monthsPer course, as listed
SKU: 06005
In Stock

Original price was: $219.00.Current price is: $185.90.

Volume pricing
1 – 4 $219.00 base price
5 – 9 $215.72 1.5 % off
10 – 19 $213.53 2.5 % off
20+ $211.34 3.5 % off
  • Juvelook 50mg is a hybrid collagen booster from VAIM Global, combining PDLLA (42.4mg) and non-crosslinked HA (7.5mg) for immediate hydration plus gradual collagen stimulation. It’s MFDS-approved and CE-certified, not FDA-approved.
In Stock
Purchase & earn 9 Points!
Quantity Discount (%) Price
1 - 4 — $185.90
5 - 9 — $215.72
10 - 19 — $213.53
20+ — $211.34
Add to Wishlist
Add to Wishlist

Professional use only. This product is intended for administration by licensed healthcare practitioners trained in the relevant anatomy and injection technique. By ordering you confirm you are authorised to purchase and handle products of this class in your jurisdiction. Availability and permitted use vary by country — please verify local regulations before ordering.

Did you like this product? Add to favorites now and follow the product.

Add to Wishlist
Add to Wishlist
Have a Question? Ask a Specialist

(+82) 10 7364 7998 Send a message on WhatsApp.

Low Prices

Price match guarantee

Guaranteed Shipment.

Always the correct part

In-House Experts.

We know our products

Easy Returns.

Quick & Hassle Free

Product overview

Juvelook 50mg: a PDLLA + HA hybrid collagen booster for skin quality

Juvelook 50mg is a hybrid collagen booster from VAIM Global Inc. in Seoul, South Korea. It combines poly-D,L-lactic acid (PDLLA) with non-crosslinked hyaluronic acid (HA) in a single lyophilised vial: 42.4 mg PDLLA and 7.5 mg HA per vial, with a particle size of 10 to 40 μm. It is not a traditional HA filler and not a pure biostimulator. It sits between the two, giving immediate hydration alongside gradual collagen stimulation.

VAIM describes patented PDLLA manufacturing technology that produces spherical, porous microparticles. Juvelook is aimed at skin quality: tone, texture, fine lines and hydration of the face. It is MFDS-approved in Korea and CE-certified in Europe, and it is not FDA-approved. It is for use by licensed professionals only.

PDLLA + HA

42.4 mg PDLLA and 7.5 mg non-crosslinked HA per vial.

Immediate hydration

The HA component gives hydration and a light plumping effect.

Gradual collagen support

The PDLLA microparticles are used to prompt collagen over time.

5 × 2 mL vials per box

Lyophilised powder, reconstituted before injection.

Key features

About Juvelook 50mg

Dual mechanism

Immediate hydration from the HA, plus gradual collagen stimulation from the PDLLA.

Porous microparticles

VAIM describes spherical, porous PDLLA microparticles made with its patented technology.

Skin-quality focus

Used for overall skin quality, tone, texture and softening of fine lines.

Companion to Juvelook Volume

Juvelook Volume (200 mg) is the higher-concentration product for deeper structural work.

Indications & Treatment Areas

Treatment areas and indications

Concerns where PDLLA + HA skin-quality boosters are used, as listed on our previous page. Approved indications differ by market.

Overall skin quality, tone and texture

Skin that looks dull or uneven, with reduced elasticity.

Fine lines and early signs of ageing

Softening of fine lines on the face.

Hydration with collagen support

For patients who want one treatment that covers both hydration and biostimulation.

A note on scope

Juvelook 50mg is an injectable medical product. Which indications are permitted and what training is required are set by the regulatory framework where you practise. Korea Filler Experts supplies the product. Nothing here is a recommendation to treat any medical condition, and nothing here replaces manufacturer training.

Composition

Juvelook 50mg specification

Product type PDLLA + HA hybrid collagen booster
PDLLA (poly-D,L-lactic acid) 42.4 mg per vial
Hyaluronic acid 7.5 mg per vial, non-crosslinked
Particle size 10 to 40 μm
Format Lyophilised powder, reconstituted before injection
Packing 5 × 2 mL vials per box
Duration (as listed) 6 to 12 months per course
Regulatory status MFDS-approved (Korea), CE-certified (Europe); not FDA-approved
Manufacturer VAIM Global Inc, South Korea
SKU 06005

Before you order

  • Regulatory status. Juvelook is MFDS-approved and CE-certified. It is not FDA-approved for the US market. Confirm the status in the country where you practise.
  • Every box ships in its original packaging with the lot number and expiry date.
  • We do not dispatch stock with under 6 months of shelf life remaining unless agreed in advance.

Priced per box (5 × 2 mL vials), with quantity discounts at five, ten and twenty boxes.

What each component does

PDLLA, 42.4 mg

Poly-D,L-lactic acid is a biodegradable polymer used in collagen biostimulators. It is derived from fermented crops and is described as prompting fibroblasts to produce new collagen over the weeks after injection.

Non-crosslinked hyaluronic acid, 7.5 mg

The HA component gives an immediate hydrating and plumping effect. It is not cross-linked, so it is absorbed relatively quickly and this effect fades within weeks if used alone.

Approved indications differ by country. Read the manufacturer’s instructions for use.

How to use

How Juvelook 50mg is used

Reference information for trained practitioners. The manufacturer’s instructions for use and training take precedence over this page, including reconstitution volume, needle or cannula, plane and volume per area.

Step by step

  1. Assess and consent

    Review medical history, allergies, autoimmune disease, scarring tendency, medication and previous treatments. Explain that part of the effect is immediate and part builds over time.

  2. Prepare the skin

    Remove make-up and cleanse thoroughly. Apply topical anaesthetic if required.

  3. Reconstitute

    Reconstitute the lyophilised powder immediately before injection, following standard aseptic technique and the instructions for use.

  4. Treat as taught

    Use the technique, depth and needle or cannula stated in the instructions for use and your training. Inject slowly with low pressure.

  5. Review

    Assess the response and decide on any follow-up treatment as a clinical decision.

Administration notes

Patients should not expect all of the result at once. The HA component gives visible hydration almost immediately, while collagen-related improvement develops over the following weeks.

  • Single use. One vial, one patient. Reconstitute immediately before use and discard any remainder.
  • Do not inject into infected, inflamed or broken skin.
  • Know how to recognise and manage nodules and vascular events.
  • Dispose of needles into a sharps container in line with local clinical waste rules.

After treatment

  • Redness, swelling, tenderness and bruising are common and settle within days
  • Follow the post-treatment advice in the instructions for use and your clinic’s protocol
  • Seek urgent review for severe pain, blanching, skin colour change or a lump that grows or becomes tender
Storage & handling

Storing and handling Juvelook 50mg

Storage

Store at room temperature, protected from direct sunlight. Do not freeze.

Before use

Use before the expiry date, and only if the packaging and vial are intact.

After reconstitution

Reconstitute immediately before use. Single patient, single session. Do not retain or reuse any remainder.

Handling and shipping note

Do not use if the packaging is damaged or the expiry date has passed. Dispose of used vials, syringes and needles as clinical waste in line with local requirements.

In the box

What's included with Juvelook 50mg

5 × 2 mL vials PDLLA 42.4 mg + HA 7.5 mg per vial, lyophilised powder
Original manufacturer packaging With lot number and expiry date
Manufacturer instructions As supplied with the product, where provided
Lot and expiry confirmation Available before dispatch on request
Tracked shipping Tracking number issued on dispatch

Reconstitution fluids, syringes, needles, cannulas and anaesthetic are not supplied unless stated in the manufacturer’s pack.

FAQ

Juvelook 50mg — frequently asked questions

What is Juvelook 50mg?

A hybrid collagen booster from VAIM Global combining PDLLA and non-crosslinked HA, giving immediate hydration and gradual collagen stimulation.

How is Juvelook different from a standard HA skin booster?

A standard HA booster mainly hydrates, and its effect fades as the HA is absorbed. Juvelook also contains PDLLA, which is used to prompt new collagen, so part of the result is designed to persist after the HA is gone.

How long do the results last?

The listing gives 6 to 12 months per course, with some skin-quality benefit reported to persist longer. It varies by patient.

Is Juvelook FDA-approved?

No. Juvelook is MFDS-approved in Korea and CE-certified in Europe, but it is not approved by the US FDA.

What is the difference between Juvelook 50mg and Juvelook Volume?

Juvelook 50mg targets skin quality and fine lines with a lower PDLLA concentration. Juvelook Volume (200 mg) uses a much higher concentration and larger particles for deeper structural volumising.

Who can buy and use this product?

Injectable products are for administration by licensed healthcare practitioners trained in injection technique. We supply qualified professionals and do not sell to consumers.